Patents by Inventor Verena Niederberger

Verena Niederberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180022808
    Abstract: The present invention relates to an antibody construct comprising at least one antigen binding site specific for ICAM1 and at least one antigen binding site specific for at least one allergen.
    Type: Application
    Filed: February 10, 2016
    Publication date: January 25, 2018
    Inventors: Christoph Madritsch, Sabine Flicker, Rudolf Valenta, Elisabeth Gader-Maier, Julia Eckl-Dorna, Verena Niederberger, Katharina Blatt, Peter Valent, Isabella Ellinger
  • Patent number: 9638694
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: May 2, 2017
    Assignee: Viravaxx GmbH
    Inventors: Rudolf Valenta, Katarzyna Niespodziana, Johanna Edlmayr, Dieter Blaas, Verena Niederberger-Leppin, Nikos Papadopoulos, Theresia Popow-Kraupp
  • Publication number: 20120213820
    Abstract: The present invention relates to a pharmaceutical composition comprising at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues comprising amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3 and VP4.
    Type: Application
    Filed: November 2, 2010
    Publication date: August 23, 2012
    Inventors: Rudolf Valenta, Katarzyna Niespodziana, Johanna Edlmayr, Dieter Blaas, Verena Niederberger-Leppin, Nikos Papadopoulos, Theresia Popow-Kraupp
  • Patent number: 7279295
    Abstract: The present invention relates to a novel allergen from timothy grass (Phleum pretense) pollen, Phl p11 as disclosed in SEQ ID NO:2, and use thereof as a reagent and in a diagnositic kit as well as for immunotherapy.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: October 9, 2007
    Assignee: Phadia AB
    Inventors: Asa Marknell Dewitt, Verena Niederberger, Pirjo Lehtonen, Susanne Spitzauer, Wolfgang R. Sperr, Peter Valent, Rudolf Valenta, Jonas Lidholm
  • Publication number: 20040014155
    Abstract: The present invention relates to a novel allergen from timothy grass (Phleum pratense) pollen, Phl p 11 as disclosed in SEQ ID NO 1, and use thereof as a reagent and in a diagnostic kit as well as for immunotherapy.
    Type: Application
    Filed: March 27, 2003
    Publication date: January 22, 2004
    Applicant: Pharmacia Diagnostics AB
    Inventors: Asa Marknell Dewitt, Verena Niederberger, Pirjo Lehtonen, Susanne Spitzauer, Wolfgang R. Sperr, Peter Valent, Rudolf Valenta, Jonas Lidholm